Psoriasis - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

Early Biomarkers of a Brain on Fire - Tom O’Bryan, DC, CCN, DACBN (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

History, Pharmacology and Mechanism - Stephen Dickson, BSC (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

Jill Cottel, MD - Vitamin D and Autoimmune Disease: A Systematic Review of the Literature (2017 Conference) (LDN, low dose naltrexone)

Beth Livengood, ND - Rheumatoid Arthritis Case Study (2017 Conference) (LDN, low dose naltrexone)

Etiology of rheumatoid arthritis (RA) is autoimmune; has an inflammatory component including food sensitivities. Low Vitamin D a component, as in many diseases. LDN in two cases of RA.

Brian Udell, MD - Review of Recent Statistics for Patients Taking LDN in a Special Needs Pediatric Practice (2017 Conference) (LDN, low dose naltrexone)

Jill Brook, MA - What the Bleep Can I Eat?! Making Sense of Conflicting Autoimmune Diets (2017 Conference) (LDN, low dose naltrexone)

Beth Livengood, ND - Gastroparesis Case Study (2017 Conference) (LDN, low dose naltrexone)

A case of gastroparesis and how low dose naltrexone helped this patient. Causes, symptoms, diagnostic findings, similar pathologies, demographics, and treatments, including diet, low dose naltrexone, acupuncture, etc; and the mechanisms of action of these treatments.

Debbie Rice, ND - LDN: regulating immune and inflammatory response (2017 Conference) (LDN, low dose naltrexone)

Two cases of Hashimoto's case where the patients stabilized on LDN. A Crohn’s case that took 3 months for LDN to have full effect

Paul Anderson, NMD - Crohn's Disease: Latest Integrative Immunologic Therapies (2017 Conference) (LDN, low dose naltrexone)

Immune dysregulation and Crohn’s Disease. Integrated medical approaches. Low dose naltrexone (LDN) dosing, management of side effects, caution on opiates and LDN. LDN works synergistically with therapies, allows reduction of other Crohn’s medications.